Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Trospium meets endpoints in phase III overactive bladder trial

Sep. 25, 2002

Cozaar reduces the risk of ESRD in patients with type 2 diabetes, nephropathy and hypertension

Sep. 23, 2002

New option available for patients with hypertension and diabetic kidney disease

Sep. 20, 2002

Resiniferatoxin: safe and effective for neurogenic and idiopathic bladder overactivity

Sep. 19, 2002

European approval for Fosrenol delayed

Sep. 18, 2002

Research findings support use of KRP-197 for overactive bladder

Sep. 18, 2002

Sustained beneficial effects reported for tadalafil in men with ED

Sep. 18, 2002

Chinese research demonstrates efficacy and safety of epristeride for BPH

Sep. 16, 2002

Pharmacokinetics, efficacy and safety of tadalafil discussed at meeting in Stockholm

Sep. 16, 2002

Clinical results for dutasteride in the treatment of BPH reported at SIU congress

Sep. 16, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...